FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety

• Pubblicazione: [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2013
• Descrizione fisica: 1 online resource (34 pages) : illustrations
• Soggetto topico: Medicare; Drugs - Risk assessment - United States - Evaluation; Drugs - United States - Safety measures - Evaluation
• Note generali: Title from title screen (viewed June 13, 2016).; "February 2013."; "OEI-04-11-00510."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Food and Drug Administration lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety; FDA lacks comprehensive data to determine whether REMS improve drug safety
• Titolo autorizzato: FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910707255503321
• Lo trovi qui: Univ. Federico II